Zoetis Inc. (NYSE:ZTS) Shares Sold by Chapman Investment Management LLC

Chapman Investment Management LLC lowered its holdings in Zoetis Inc. (NYSE:ZTS) by 1.7% in the fourth quarter, Holdings Channel.com reports. The fund owned 22,617 shares of the company’s stock after selling 385 shares during the quarter. Zoetis makes up 3.4% of Chapman Investment Management LLC’s investment portfolio, making the stock its 11th largest position. Chapman Investment Management LLC’s holdings in Zoetis were worth $4,464,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of ZTS. Blue Bell Private Wealth Management LLC raised its stake in shares of Zoetis by 222.5% during the 4th quarter. Blue Bell Private Wealth Management LLC now owns 129 shares of the company’s stock worth $25,000 after buying an additional 89 shares during the last quarter. Independence Bank of Kentucky raised its stake in shares of Zoetis by 371.4% during the 4th quarter. Independence Bank of Kentucky now owns 165 shares of the company’s stock worth $33,000 after buying an additional 130 shares during the last quarter. Moisand Fitzgerald Tamayo LLC raised its stake in shares of Zoetis by 105.5% during the 3rd quarter. Moisand Fitzgerald Tamayo LLC now owns 187 shares of the company’s stock worth $33,000 after buying an additional 96 shares during the last quarter. Ramirez Asset Management Inc. acquired a new position in shares of Zoetis during the 3rd quarter worth $35,000. Finally, First Financial Corp IN raised its stake in shares of Zoetis by 57.2% during the 4th quarter. First Financial Corp IN now owns 217 shares of the company’s stock worth $43,000 after buying an additional 79 shares during the last quarter. Institutional investors and hedge funds own 92.80% of the company’s stock.

Analyst Ratings Changes

ZTS has been the subject of a number of recent research reports. Barclays dropped their price objective on Zoetis from $260.00 to $230.00 and set an “overweight” rating for the company in a research report on Tuesday. StockNews.com cut Zoetis from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, February 20th. The Goldman Sachs Group lifted their price objective on Zoetis from $190.00 to $226.00 and gave the stock a “buy” rating in a research report on Wednesday, January 17th. Stifel Nicolaus dropped their price objective on Zoetis from $215.00 to $195.00 and set a “buy” rating for the company in a research report on Tuesday, April 2nd. Finally, Piper Sandler reiterated an “overweight” rating and set a $195.00 price objective (down previously from $220.00) on shares of Zoetis in a research report on Tuesday, April 16th. Eight investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus price target of $218.00.

Zoetis Trading Up 3.3 %

ZTS traded up $5.06 during midday trading on Friday, hitting $158.42. The company’s stock had a trading volume of 5,236,463 shares, compared to its average volume of 4,019,007. The company has a current ratio of 3.36, a quick ratio of 2.00 and a debt-to-equity ratio of 1.32. The firm has a market cap of $72.45 billion, a P/E ratio of 31.25, a PEG ratio of 2.34 and a beta of 0.85. The firm has a 50-day moving average price of $171.79 and a two-hundred day moving average price of $179.29. Zoetis Inc. has a 52-week low of $144.80 and a 52-week high of $201.92.

Zoetis (NYSE:ZTS) last issued its earnings results on Tuesday, February 13th. The company reported $1.24 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.32 by ($0.08). Zoetis had a return on equity of 51.25% and a net margin of 27.43%. The firm had revenue of $2.21 billion for the quarter, compared to analysts’ expectations of $2.19 billion. During the same quarter in the previous year, the firm posted $1.15 EPS. The firm’s revenue for the quarter was up 8.5% compared to the same quarter last year. On average, research analysts anticipate that Zoetis Inc. will post 5.79 earnings per share for the current year.

Zoetis Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 4th. Stockholders of record on Friday, April 19th will be issued a dividend of $0.432 per share. This represents a $1.73 dividend on an annualized basis and a dividend yield of 1.09%. The ex-dividend date is Thursday, April 18th. Zoetis’s payout ratio is currently 34.12%.

Insider Transactions at Zoetis

In other news, EVP Roxanne Lagano sold 363 shares of the business’s stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $197.74, for a total transaction of $71,779.62. Following the completion of the sale, the executive vice president now owns 20,417 shares in the company, valued at approximately $4,037,257.58. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In the last quarter, insiders sold 2,209 shares of company stock worth $371,293. 0.12% of the stock is currently owned by company insiders.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.